Nasodine® Throat Spray launches in Singapore

  21 Jan 2026

Firebrick Pharma (ASX:FRE) is very pleased to announce that its new product – Nasodine® Throat Spray – has been launched in Singapore. This follows successful completion of commercial manufacturing in Australia in November and December 2025, and shipment to Singapore in early January 2026.

Nasodine Throat Spray is a 1% povidone-iodine solution designed for oral use. The Company considers the new throat spray to be a valuable complement to Nasodine Nasal Spray because it targets sore throats, which are often the first sign of the common cold.

“Nasodine Throat Spray provides a compact, easy-to-use and pleasant tasting solution for sore throats,” said Firebrick Executive Chairman, Dr Peter Molloy.

“In conjunction with our nasal spray, the new throat spray gives cold sufferers a comprehensive nasal and oral solution for protection and relief of colds. We believe the convenience of the throat spray compared to oral gargles is a major benefit; it’s perfect for travel, commuting and other on-the-go uses.”

Nasodine Throat Spray is being launched in Singapore by the Company’s exclusive licensing partner, Innorini Life Sciences. For the first six months Innorini’s focus will be on hospitals and healthcare professionals (“HCPs”), after which the new throat spray will be made available to the retail channel.

Innorini Managing Director, Rishi Nandiraju stated: “Following the strong response to Nasodine Nasal Spray in Singapore, we are extremely excited to introduce the Nasodine Throat Spray to the market. This represents a natural extension of the brand and a significant opportunity to strengthen Nasodine as a
comprehensive first-line antiseptic solution for upper respiratory care. We see strong potential across both the HCP and retail channels, and we look forward to working closely with Firebrick to build Nasodine into a trusted household name in Singapore.”

Firebrick also expects to see the Nasodine Throat Spray introduced in Fiji and USA during 2026, and in other markets in the future where Nasodine Nasal Spray is approved. Other new Nasodine products are also planned for introduction in existing markets in 2026.

“We are aiming to build a valuable Nasodine franchise that based multiple products across multiple markets,” added Dr Molloy.